These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32161419)

  • 1. Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26).
    Kerr AJ; Mitnala S; Lee M; White HD
    N Z Med J; 2020 Mar; 133(1511):21-40. PubMed ID: 32161419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic differences in the initiation and maintenance of statins in the first year post ACS in New Zealand: a data linkage study (ANZACS-QI 57).
    Muniandy A; Lee M; Grey C; Ferrier K; Kerr AJ
    N Z Med J; 2021 Apr; 134(1534):31-45. PubMed ID: 33927436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2).
    Grey C; Jackson R; Wells S; Thornley S; Marshall R; Crengle S; Harrison J; Riddell T; Kerr A
    Heart; 2014 May; 100(10):770-4. PubMed ID: 24436219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide dispensing of cardioprotective medications during the first year following acute coronary syndrome (ANZACS-QI 56).
    Butchard M; Kerr AJ; Grey C; Wu B; Hider P
    N Z Med J; 2021 Mar; 134(1531):36-54. PubMed ID: 33767486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome.
    Wongsalap Y; Jedsadayanmata A
    J Cardiol; 2020 Mar; 75(3):275-281. PubMed ID: 31519405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation and maintenance of statins and aspirin after acute coronary syndromes (ANZACS-QI 11).
    Kerr AJ; Turaga M; Grey C; Lee M; McLachlan A; Devlin G
    J Prim Health Care; 2016 Sep; 8(3):238-249. PubMed ID: 29530207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study.
    Liu H; Dong A; Wang H
    Medicine (Baltimore); 2018 Oct; 97(42):e12687. PubMed ID: 30334951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction.
    Tungsubutra W; Phongtuntakul B
    J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization.
    Vlachopoulos C; Andrikopoulos G; Terentes-Printzios D; Tzeis S; Iliodromitis EK; Richter D; Mantas I; Kartalis A; Vasilikos V; Stakos D; Patsilinakos S; Lampropoulos S; Symeonidis D; Kyrpizidis C; Marinakis N; Nikas N; Lekakis J; Tousoulis D; Vardas P
    Curr Vasc Pharmacol; 2018; 16(4):405-413. PubMed ID: 28676022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the Statin Possession Ratio Cut-Off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)?
    Ali M; Kerr AJ; Lee M; Chan DZL
    Heart Lung Circ; 2023 Apr; 32(4):487-496. PubMed ID: 36641263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies.
    Sun Y; Xie G; Patel A; Li S; Zhao W; Yang X; Wu T; Li M; Li X; Du X; Hu R; Huo Y; Hu D; Gao RL; Wu Y
    Clin Cardiol; 2018 Sep; 41(9):1192-1200. PubMed ID: 30084224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.
    Hajahmadi Pourrafsanjani M; Khayati Shal E; Khezrpour S
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):37-43. PubMed ID: 30684247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
    Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
    J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of capture of coronary intervention and associated acute coronary syndromes in the all New Zealand acute coronary syndrome quality improvement cardiac registry and excellent agreement with national administrative datasets (ANZACS-QI 25).
    Kerr AJ; Lee M; Jiang Y; Grey C; Wells S; Williams M; Jackson R; Poppe K
    N Z Med J; 2019 Mar; 132(1492):19-29. PubMed ID: 30921308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.